Clinical evidence yield as a framework for evaluating computational predictors and multiplexed assays of variant effect
This paper introduces mean evidence strength (MES), a novel metric based on ACMG/AMP guidelines and Bayesian calibration, to evaluate computational predictors and multiplexed assays of variant effect by quantifying their clinical evidence yield rather than relying solely on traditional discrimination metrics like AUROC.